New drug for recurring malaria :: Healthwatch Derby
  • Text size
  • A
  • A
  • A
Your spotlight on local services

New drug for recurring malaria


 A new drug to treat malaria has been given the green light by authorities in the United States.

The medicine is specifically for the recurring form of malaria - caused by the parasite plasmodium vivax- which makes 8.5 million people ill each year.

This type of malaria is a particular challenge to get rid of as it can remain dormant in the liver for years before reawakening many times.

Scientists have described tafenoquine as a "phenomenal achievement."

Read more



Sign up for our newsletter and be the first to find out what is happening.

Email info@